Research Chance for Active Contributors
In an exciting development, researchers at the QIMR Berghofer Medical Research Institute in Brisbane are conducting an Australian study to investigate genetic factors that influence a person's risk of developing Parkinson's disease.
The study's primary objective is to use the genetic data collected from participants to predict and potentially prevent the onset and progression of Parkinson's disease. To achieve this, participants will be asked to fill in a short questionnaire, either online, over the phone, or via mail. A kit will be mailed to participants for collecting saliva samples, which will be used to extract DNA.
The study aims to find genetic variants that can help predict and prevent Parkinson's onset and progression. Participants may have a care partner or support person help them complete the questionnaire if needed. It's important to note that while Parkinson’s disease genetic studies often focus on well-known genes such as SNCA, LRRK2, and GBA, the precise genetic variants targeted by this specific project are not identified in the available search results.
Interested individuals can participate in the study, regardless of their location, as the questionnaire is available online. QIMR Berghofer Medical Research Institute, a world-leading institute based in Brisbane with around 900 researchers, scientists, students, and support staff, researches chronic disorders, cancer, mental health, and infectious diseases.
For more detailed information on the specific genetic variants being investigated in this study, visitors are encouraged to explore the QIMR Berghofer Medical Research Institute’s official website or their publications on Parkinson’s disease.
Joining this study could be a significant step towards understanding the genetic factors that contribute to the risk of developing Parkinson's disease and potentially paving the way for preventive measures. If you or someone you know is interested, please consider contributing to this valuable research.
- This study, conducted by QIMR Berghofer Medical Research Institute, combines science and medical research to investigate genetic factors that influence the risk of developing neurological disorders, specifically Parkinson's disease.
- The health-and-wellness initiative aims to discover genetic variants that can help predict and prevent Parkinson's onset and progression, and could lead to breakthroughs in therapies-and-treatments for neurological-disorders.
- The institute's research contributes significantly to the field of medical research, focusing on chronic disorders, cancer, mental health, and infectious diseases, while also addressing the pressing issue of cancer and developing approaches to mitigate its impact.
